Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

RPH Pharmaceuticals AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 37,630 Less Arrow 29,686 Less Arrow 20,740
Financial expenses 2,648 More Arrow 2,891 Less Arrow 1,609
Earnings before taxes 11,133 Less Arrow 4,004 Less Arrow 3,342
EBITDA 11,601 Less Arrow 9,851 Less Arrow 6,697
Total assets 22,545 More Arrow 28,851 Less Arrow 27,019
Current assets 6,431 More Arrow 9,759 Less Arrow 8,512
Current liabilities 17,735 More Arrow 25,121 Less Arrow 22,940
Equity capital 4,556 Less Arrow 3,467 More Arrow 3,816
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 20.2% Less Arrow 12.0% More Arrow 14.1%
Turnover per employee
Profit as a percentage of turnover 29.6% Less Arrow 13.5% More Arrow 16.1%
Return on assets (ROA) 61.1% Less Arrow 23.9% Less Arrow 18.3%
Current ratio 36.3% More Arrow 38.8% Less Arrow 37.1%
Return on equity (ROE) 244.4% Less Arrow 115.5% Less Arrow 87.6%
Change turnover 8,954 Less Arrow 8,886 Less Arrow 4,582
Change turnover % 31% More Arrow 43% Less Arrow 28%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.